Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus

Published:2016-05-19 Issue:5 Volume:7 Page:727-736
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Ji Linong¹,Han Ping²,Wang Xiaoyue³,Liu Jingdong⁴,Zheng Shaoxiong⁵,Jou Ying‐Ming⁶,O'Neill Edward A⁶,Golm Gregory T⁶,Engel Samuel S⁶,Kaufman Keith D⁶,Shankar R Ravi⁶

Affiliation:

1. Peking University People's Hospital Beijing China

2. Shengjing Hospital China Medical University Shenyang China

3. The First People's Hospital of Yueyang Yueyang China

4. Jiangxi Province People's Hospital Nanchang China

5. The Second Hospital of Tianjin Medical University Tianjin China

6. Merck & Co., Inc Kenilworth New Jersey USA

Funder

Merck

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.12511

Reference26 articles.

1. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030

2. Diabetes — a common, growing, serious, costly, and potentially preventable public health problem

3. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry;Karter AJ;Am J Manag Care,2005

4. The biology of incretin hormones

5. Sitagliptin: A Review of Its Use in Patients with Type 2 Diabetes Mellitus

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30

2. Saxagliptin combined with additional oral antihyperglycaemic agents in drug‐naive diabetic patients with high glycosylated haemoglobin: A 24‐week, multicentre, randomized, open‐label, active parallel‐controlled group clinical trial in China ( SUCCESS );Diabetes, Obesity and Metabolism;2022-10-14

3. Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients;Biomedicines;2022-10-12

4. Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-09-16

5. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials;Frontiers in Endocrinology;2022-09-14